Malaria: Difference between revisions

Line 243:

[https://tropmedhealth.biomedcentral.com/articles/10.1186/s41182-023-00516-w by Amal A. El-Moamly 17/5/23 BMC]

This review highlights the history of development, and the different approaches and types of malaria vaccines, and the literature to date. It covers the developmental stages of RTS,S/AS01 and recommends steps for its deployment. The review explores other potential vaccine candidates and their status, and suggests options for their further development. It also recommends future roles for vaccines in eradicating malaria. Questions remain on how RTS,S vaccine will work in widespread use and how it can best be utilized to benefit vulnerable communities.

=====Malaria: The malaria vaccine implementation programme (MVIP)=====

[https://www.who.int/news-room/questions-and-answers/item/malaria-vaccine-implementation-programme by World Health Organization]

Beginning in 2019, 3 sub-Saharan African countries – Ghana, Kenya and Malawi – led the introduction of the vaccine in selected areas of moderate-to-high malaria transmission as part of a large-scale pilot programme coordinated by WHO. The aim is to vaccinate about 360 000 children per year in the selected areas across the 3 countries. Vaccinations are being provided through each country’s routine immunization programme.

Malaria: Difference between revisions

Lilly (talk | contribs)

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 243: / Line 243: @@
 [https://tropmedhealth.biomedcentral.com/articles/10.1186/s41182-023-00516-w by Amal A. El-Moamly 17/5/23 BMC]
   This review highlights the history of development, and the different approaches and types of malaria vaccines, and the literature to date. It covers the developmental stages of RTS,S/AS01 and recommends steps for its deployment. The review explores other potential vaccine candidates and their status, and suggests options for their further development. It also recommends future roles for vaccines in eradicating malaria. Questions remain on how RTS,S vaccine will work in widespread use and how it can best be utilized to benefit vulnerable communities.
+=====Malaria: The malaria vaccine implementation programme (MVIP)=====
+[https://www.who.int/news-room/questions-and-answers/item/malaria-vaccine-implementation-programme by World Health Organization]
+ Beginning in 2019, 3 sub-Saharan African countries – Ghana, Kenya and Malawi – led the introduction of the vaccine in selected areas of moderate-to-high malaria transmission as part of a large-scale pilot programme coordinated by WHO. The aim is to vaccinate about 360 000 children per year in the selected areas across the 3 countries. Vaccinations are being provided through each country’s routine immunization programme.